申请人:Boehringer Mannheim GmbH
公开号:US04443477A1
公开(公告)日:1984-04-17
The invention provides sulphonamides of the formula ##STR1## wherein R is a hydrogen atom or a lower alkyl radical; R.sub.1 is alkyl, aryl, aralkyl or aralkenyl, the aryl moiety of which in each case can be optionally substituted one or more times by hydroxyl, halogen, trifluoromethyl, lower alkyl or alkoxy or by acyl, carboxy or alkoxycarbonyl; n is 1, 2 or 3; and W is a valence bond or a divalent aliphatic hydrocarbon linkage and the physiologically acceptable salts, esters and amides of such compound. These compounds have excellent pharmacological lipid depressing activity and inhibit thrombocyte aggregation.
该发明提供了以下结构的磺胺类化合物:##STR1## 其中R为氢原子或低碳基基团;R.sub.1为烷基、芳基、芳基烷基或芳基烯基,其中每种情况下的芳基部分可以选择性地通过羟基、卤素、三氟甲基、低碳基或烷氧基或酰基、羧基或烷氧羰基取代一次或多次;n为1、2或3;W为价键或二价脂肪族碳链,以及该化合物的生理学上可接受的盐、酯和酰胺。这些化合物具有出色的药理学降脂活性,并抑制血小板聚集。